In conclusion, the present study showed elevated levels of CTRP9 in T2DM and CAD patients as well as positive correlations of CTRP9 with BMI, glucose metabolism parameters, inflammatory markers and adhesion molecules and a negative correlation with adiponectin. This evidence concerns the gene ADIPOQ and coronary artery disorder.